BiotechTube
Home/Electra Therapeutics/Kathy Dong
KD

Kathy Dong

President and CEO

Electra Therapeutics

Therapeutic Areas

ImmunologyOncology

Electra Therapeutics Pipeline

DrugIndicationPhase
ELA026Secondary Hemophagocytic Lymphohistiocytosis (sHLH)Phase 2/3
ELA822Immunology & Inflammation DiseasesPreclinical